Skip to main content

Table 1 Basic characteristics of patients

From: Glucocorticoid therapy reduces ocular hypertension in active moderate-severe thyroid-associated orbitopathy

Characteristics

 

Age, years

49.97 ± 13.83

Male/Female, n

40/28

GD/HT,n

64/4

Previous thyroid treatment, n

 Anti-thyroid drug

59

 RAI

5

 Thyroidectomy

0

 L-T4

4

Duration of eye symptoms, month

6.89 ± 8.52

Exophthalmometry, R,mm

19.8 ± 3.36

Exophthalmometry, L,mm

19.53 ± 3.69

 CAS,R

3.85 ± 0.9

 CAS,L

3.85 ± 0.93

IOP

 Non-OHT, n

75

 mild hypertension (20-30 mmHg), n

50

 moderate hypertension (30-40 mmHg), n

8

 severe hypertension (> 40 mmHg), n

3

  1. Data represented as mean ± SD
  2. HT Hashimoto disease, GD Grave’s disease, RAI radioiodine therapy, L-T4 levothyroxine, CAS Clinical activity score, IOP Intraocular Pressure, OHT Ocular hypertension, n number